Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		01388naa a2200313 4500
001		oai:prod.swepub.kib.ki.se:136499831
003		SwePub
008		240913s2017 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
024	7	a http://kipublications.ki.se/Default.aspx?queryparsed=id:1364998312 URI
024	7	a https://doi.org/10.1186/s12885-017-3577-x2 DOI
040		a (SwePub)ki
041		a eng
042		9 SwePub
072	7	a ref2 swepub-contenttype
072	7	a art2 swepub-publicationtype
100	1	a Falkenius, J4 aut
245	1 0	a Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma
264		c 2017-08-29
264	1	b Springer Science and Business Media LLC,c 2017
700	1	a Johansson, Hu Karolinska Institutet4 aut
700	1	a Tuominen, Ru Karolinska Institutet4 aut
700	1	a Stolt, MF4 aut
700	1	a Hansson, Ju Karolinska Institutet4 aut
700	1	a Brage, SEu Karolinska Institutet4 aut
710	2	a Karolinska Institutet4 org
773	0	t BMC cancerd : Springer Science and Business Media LLCg 17:1, s. 584-q 17:1<584-x 1471-2407
856	4	u https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-017-3577-x
856	4 8	u http://kipublications.ki.se/Default.aspx?queryparsed=id:136499831
856	4 8	u https://doi.org/10.1186/s12885-017-3577-x

By the author/editor: Falkenius, J; Johansson, H; Tuominen, R; Stolt, MF; Hansson, J; Brage, SE

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.